Thorac Cardiovasc Surg 2013; 61(02): 124-130
DOI: 10.1055/s-0032-1304543
Original Thoracic
Georg Thieme Verlag KG Stuttgart · New York

Severity of Chronic Obstructive Pulmonary Disease and Its Relationship to Lung Cancer Prognosis after Surgical Resection[*]

Yasuo Sekine
1   Department of Thoracic Surgery, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan
,
Hidemi Suzuki
1   Department of Thoracic Surgery, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan
,
Yoshito Yamada
2   Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
,
Eitetsu Koh
1   Department of Thoracic Surgery, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan
,
Ichiro Yoshino
2   Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
› Author Affiliations
Further Information

Publication History

02 September 2011

21 November 2011

Publication Date:
25 April 2012 (online)

Abstract

Objective The purpose was to determine the rates of postoperative pulmonary complications, and to clarify the impact of COPD on long-term survival in lung cancer patients after surgical resection.

Methods A retrospective chart review was performed on 1,461 patients who had undergone pulmonary resection for lung cancer from 1990 to 2005. Classification of COPD severity was based on spirometric guidelines of the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Postoperative complication rates among the four COPD groups were compared and long-term overall and disease-specific survivals were analyzed.

Results The frequencies of all pulmonary complications in three COPD groups were higher than in the non-COPD group (all p < 0.05). Overall and disease-specific survivals were significantly worse in relation to higher COPD grades (all p ≤ 0.05). Significant prognostic factors were age, body mass index, positive smoking history, tumor size, pneumonectomy, pathologic stage, and COPD grade (p < 0.05).

Conclusion Higher COPD grades had higher rates of postoperative pulmonary complications and poorer long-term survivals because of higher rates of cancer-related deaths.

* This paper was presented at the 54th Annual Meeting of the Thomas L. Petty Aspen Lung Conference in Colorado, USA, 2011.


 
  • References

  • 1 Brunelli A, Charloux A, Bolliger CT , et al; European Respiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009; 34 (1) 17-41
  • 2 Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT. American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl) 161S-177S
  • 3 Sekine Y, Kesler KA, Behnia M, Brooks-Brunn J, Sekine E, Brown JW. COPD may increase the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer. Chest 2001; 120 (6) 1783-1790
  • 4 Licker MJ, Widikker I, Robert J , et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg 2006; 81 (5) 1830-1837
  • 5 Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer 2002; 37 (1) 95-101
  • 6 López-Encuentra A, Astudillo J, Cerezal J, Gonzalez-Aragoneses F, Novoa N, Sánchez-Palencia A. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer. Eur J Cardiothorac Surg 2005; 27 (1) 8-13
  • 7 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152 (5 Pt 2) S77-S121
  • 8 Sekine Y, Yamada Y, Chiyo M , et al. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection. Ann Thorac Surg 2007; 84 (3) 946-950
  • 9 Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009; 34 (2) 380-386
  • 10 Wilson DO, Weissfeld JL, Balkan A , et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178 (7) 738-744
  • 11 Congleton J, Muers MF. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med 1995; 89 (4) 291-296
  • 12 Kurishima K, Satoh H, Ishikawa H , et al. Lung cancer patients with chronic obstructive pulmonary disease. Oncol Rep 2001; 8 (1) 63-65
  • 13 Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of comorbidities. Eur Respir J 2006; 28 (6) 1245-1257
  • 14 Cooper JD, Trulock EP, Triantafillou AN , et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109 (1) 106-116 , discussion 116–119
  • 15 Choong CK, Meyers BF, Battafarano RJ , et al. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg 2004; 127 (5) 1323-1331
  • 16 Benzo R, Farrell MH, Chang CC , et al; NETT Research Group. Integrating health status and survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit Care Med 2009; 180 (3) 239-246
  • 17 Fessler HE, Scharf SM, Ingenito EP, McKenna Jr RJ, Sharafkhaneh A. Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thorac Soc 2008; 5 (4) 416-420
  • 18 Sekine Y, Iwata T, Chiyo M , et al. Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease. Ann Thorac Surg 2003; 76 (2) 356-361 , discussion 362
  • 19 Baldi S, Ruffini E, Harari S , et al. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. J Thorac Cardiovasc Surg 2005; 130 (6) 1616-1622
  • 20 Ginsberg RJ, Rubinstein LV. Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60 (3) 615-622 , discussion 622–623
  • 21 Nakamura H, Kawasaki N, Taguchi M, Kabasawa K. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis. Br J Cancer 2005; 92 (6) 1033-1037
  • 22 Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003; 125 (4) 924-928
  • 23 Griffin JP, Eastridge CE, Tolley EA, Pate JW. Wedge resection for non-small cell lung cancer in patients with pulmonary insufficiency: prospective ten-year survival. J Thorac Oncol 2006; 1 (9) 960-964
  • 24 Volpino P, Cangemi R, Fiori E , et al. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer. J Cardiovasc Surg (Torino) 2007; 48 (3) 375-383
  • 25 Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22 (2) 268-273